UCB - Current Liabilities

Stock Price
270.20
Daily Change
-5.90 -2.14%
Monthly
4.32%
Yearly
48.38%
Q1 Forecast
269.39

UCB reported EUR3.53B in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Alcon AG USD 2.99B 566M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Amarin USD 182.23M 3.71M Sep/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 28.96B 825M Sep/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 8.64B 1.22B Sep/2025
Novartis USD 32B 286M Sep/2025
Orion EUR 560.3M 9.8M Dec/2025
Recordati EUR 1.04B 24.44M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024
Unibail Rodamco EUR 5.17B 181.4M Dec/2024